Your browser doesn't support javascript.
loading
Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis.
Li, Han-Dong; Li, Ran; Kong, Ying; Zhang, Wenyan; Qi, Caiyun; Wang, Dan; Hao, Hongying; Liu, Qiang.
Afiliación
  • Li HD; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Li R; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Kong Y; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang W; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Qi C; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang D; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Hao H; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu Q; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
Front Immunol ; 13: 801727, 2022.
Article en En | MEDLINE | ID: mdl-35720286
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Accidente Cerebrovascular Isquémico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Accidente Cerebrovascular Isquémico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza